We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OMV:VIEOMV AG Analysis

Data as of 2026-03-14 - not real-time

€58.80

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

OMV shares are trading at €58.8, comfortably above the 20‑day SMA (€56.14) and the 200‑day SMA (€47.99), signalling a bullish price trend, but the RSI of 68 flags an overbought condition. Technical indicators (bullish MACD, increasing volume) support short‑term upside, yet the price sits near the identified resistance level of €59.7. On the valuation side, the current forward P/E of ~10.4 is attractive, but the trailing P/E of 24 exceeds the industry average of 22.2, and the model‑derived upside/downside metric shows the stock is roughly 11% above its fair‑value estimate, indicating overvaluation. Fundamentals are weaker: revenue fell 30%, free cash flow is negative, and the payout ratio of 126% makes the 5.44% dividend yield unsustainable. Recent material news—including the sale of the 50% stake in SapuraOMV for about $903‑$957 million and the receipt of €81.6 million EU funding for a ReOil plant—reflects a strategic shift toward sustainable chemicals and gas diversification, but the impact on earnings remains uncertain.
Overall, the stock presents a mixed picture: bullish technical momentum tempered by deteriorating operating metrics, an elevated valuation relative to intrinsic estimates, and a dividend that may be cut. Investors should weigh the short‑term price strength against the longer‑term execution risk of OMV’s transformation plan.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price near resistance and overbought RSI
  • Current valuation ~11% above fair‑value estimate
  • Unsustainable dividend payout ratio

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward P/E suggests earnings improvement
  • Strategic divestiture and EU funding may improve cash flow
  • Persistent revenue decline and negative free cash flow

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Transition toward sustainable chemicals and gas assets
  • High sector volatility and regulatory pressure on fossil fuels
  • Uncertainty around execution of the 2030 sustainability roadmap

Key Metrics & Analysis

Financial Health

Revenue Growth-29.70%
Profit Margin4.56%
P/E Ratio24.0
ROE5.14%
ROA4.17%
Debt/Equity35.44
P/B Ratio1.3
Op. Cash Flow€5.2B
Free Cash Flow€-5047750144
Industry P/E22.2

Technical Analysis

TrendBullish
RSI68.1
Support€54.00
Resistance€59.70
MA 20€56.14
MA 50€52.62
MA 200€47.99
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value€146.48
Target Price€52.21
Upside/Downside-11.21%
GradeOvervalued
TypeBlend
Dividend Yield5.44%

Risk Assessment

Beta0.21
Volatility28.51%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.